Rising Counterfeit Trade Threatens Eli Lilly's Weight-Loss Drug
TL;DR Summary
Bloomberg's website is displaying a message asking users to ensure their browser supports JavaScript and cookies, and that they are not blocking them from loading. Users are directed to contact the support team for assistance.
- Lilly Files Trade Complaint To Block Weight-Loss Drug Knock-Offs Bloomberg
- Eli Lilly hit by illicit versions of next-gen obesity drug Seeking Alpha
- Demand for weight-loss drugs fuels global rise in counterfeits Reuters
- Hundreds of online sellers are offering an Eli Lilly weight-loss drug that’s years away from regulatory approval: WSJ MarketWatch
Reading Insights
Total Reads
0
Unique Readers
9
Time Saved
0 min
vs 1 min read
Condensed
39%
57 → 35 words
Want the full story? Read the original article
Read on Bloomberg